Vascular deposition of complement C4d is increased in liver allografts with chronic rejection

Transplant Immunology

Volumn 21, Issue 4, 2009, Pages 244-246

  Martelius, Timi ^a   Halme, Leena ^a   Arola, Johanna ^a   Höckerstedt, Krister ^a   Lautenschlager, Irmeli ^a  

^a HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

Author keywords

C4d; Chronic rejection; Liver

Indexed keywords

COMPLEMENT COMPONENT C4D;

ADULT; ARTICLE; CENTRAL VEIN; CHRONIC GRAFT REJECTION; CLINICAL ARTICLE; COMPLEMENT DEPOSITION; COMPLEMENT SYSTEM; CONTROLLED STUDY; EXPLANT; FROZEN SECTION; HUMAN; HUMAN TISSUE; LIVER BIOPSY; LIVER GRAFT REJECTION; LIVER TRANSPLANTATION; PORTAL VEIN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RETRANSPLANTATION;

ADULT; ANTIBODY-DEPENDENT CELL CYTOTOXICITY; COMPLEMENT C4B; DELAYED GRAFT FUNCTION; FEMALE; GRAFT REJECTION; HISTOCOMPATIBILITY TESTING; HUMANS; ISOANTIBODIES; LIVER; LIVER TRANSPLANTATION; MALE; MIDDLE AGED; PEPTIDE FRAGMENTS; PORTAL VEIN; TRANSPLANTATION, HOMOLOGOUS;

EID: 68649122326     PISSN: 09663274     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.trim.2009.06.004     Document Type: Article

References (19)

1. Vongwiwatana A., Gourishankar S., Campbell P.M., Solez K., and Halloran P.F. Peritubular capillary changes and C4d deposits are associated with transplant glomerulopathy but not IgA nephropathy. Am J Transplant 4 (2004) 124-129
2. Regele H., Bohmig G.A., Habicht A., Gollowitzer D., Schillinger M., Rockenschaub S., et al. Capillary deposition of complement split product C4d in renal allografts is associated with basement membrane injury in peritubular and glomerular capillaries: a contribution of humoral immunity to chronic allograft rejection. J Am Soc Nephrol. 13 (2002) 2371-2380
3. Batal I., Girnita A., Zeevi A., Saab B.A., Stockhausen S., Shapiro R., et al. Clinical significance of the distribution of C4d deposits in different anatomic compartments of the allograft kidney. Mod Pathol. 21 (2008) 1490-1498
4. Schmeding M., Dankof A., Krenn V., Krukemeyer M.G., Koch M., Spinelli A., et al. C4d in acute rejection after liver transplantation-a valuable tool in differential diagnosis to hepatitis C recurrence. Am J Transplant 6 (2006) 523-530
5. Sawada T., Shimizu A., Kubota K., Fuchinoue S., and Teraoka S. Lobular damage caused by cellular and humoral immunity in liver allograft rejection. Clin Transplant. 19 (2005) 110-114
6. Matinlauri I.H., Hockerstedt K.A., and Isoniemi H.M. Equal overall rejection rate in pre-transplant flow-cytometric cross-match negative and positive adult recipients in liver transplantation. Clin Transplant 19 (2005) 626-631
7. Takakura K., Kiuchi T., Kasahara M., Uryuhara K., Uemoto S., Inomata Y., et al. Clinical implications of flow cytometry crossmatch with T or B cells in living donor liver transplantation. Clin Transplant 15 (2001) 309-316
8. Donaldson P.T., Thomson L.J., Heads A., Underhill J.A., Vaughan R.W., Rolando N., et al. IgG donor-specific crossmatches are not associated with graft rejection or poor graft survival after liver transplantation. An assessment by cytotoxicity and flow cytometry. Transplantation 60 (1995) 1016-1023
9. Ashihara E., Tsuji H., Sakashita H., Haga H., Yurugi K., Kimura S., et al. Antidonor antibody in patients receiving ABO-identical and HLA-mismatched living donor liver transplants: effect on survival. Transplantation 83 (2007) 506-509
10. Sakashita H., Haga H., Ashihara E., Wen M.C., Tsuji H., Miyagawa-Hayashino A., et al. Significance of C4d staining in ABO-identical/compatible liver transplantation. Mod Pathol 20 (2007) 676-684
11. Troxell M.L., Higgins J.P., and Kambham N. Evaluation of C4d staining in liver and small intestine allografts. Arch Pathol Lab Med 130 (2006) 1489-1496
12. Bellamy C.O., Herriot M.M., Harrison D.J., and Bathgate A.J. C4d immunopositivity is uncommon in ABO-compatible liver allografts, but correlates partially with lymphocytotoxic antibody status. Histopathology 50 (2007) 739-749
13. Demetris A., Adams D., Bellamy C., Blakolmer K., Clouston A., Dhillon A.P., et al. Update of the International Banff Schema for Liver Allograft Rejection: working recommendations for the histopathologic staging and reporting of chronic rejection. An International Panel Hepatology 31 (2000) 792-799
14. Lautenschlager I., Linnavuori K., and Hockerstedt K. Human herpesvirus-6 antigenemia after liver transplantation. Transplantation 69 (2000) 2561-2566
15. Amos D.B., Bashir H., Boyle W., MacQueen M., and Tiilikainen A. A simple micro cytotoxicity test. Transplantation 7 (1969) 220-223
16. Haga H., Egawa H., Fujimoto Y., Ueda M., Miyagawa-Hayashino A., Sakurai T., et al. Acute humoral rejection and C4d immunostaining in ABO blood type-incompatible liver transplantation. Liver Transpl 12 (2006) 457-464
17. Matinlauri I.H., Nurminen M.M., Hockerstedt K.A., and Isoniemi H.M. Risk factors predicting survival of liver transplantation. Transplant.Proc. 37 (2005) 1155-1160
18. Evans P.C., Soin A., Wreghitt T.G., Taylor C.J., Wight D.G., and Alexander G.J. An association between cytomegalovirus infection and chronic rejection after liver transplantation. Transplantation 69 (2000) 30-35
19. Lautenschlager I., Harma M., Hockerstedt K., Linnavuori K., Loginov R., and Taskinen E. Human herpesvirus-6 infection is associated with adhesion molecule induction and lymphocyte infiltration in liver allografts. J Hepatol 37 (2002) 648-654